Literature DB >> 23319695

Prolonged survival of a patient with papillary renal cell carcinoma and brain metastases using pazopanib.

Corbin Jacobs1, Dong Wook Nathan Kim, Christopher Straka, Robert D Timmerman, James Brugarolas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23319695     DOI: 10.1200/JCO.2012.46.0501

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  13 in total

Review 1.  Leptomeningeal Metastases.

Authors:  Jerome J Graber; Santosh Kesari
Journal:  Curr Treat Options Oncol       Date:  2018-01-23

2.  Immune-checkpoint inhibitors in brain metastases from renal cell carcinoma: a battle was lost but not the war.

Authors:  Giuseppe Lombardi; Marco Maruzzo; Giuseppe Minniti; Marta Padovan; Mario Caccese; Vittorina Zagonel
Journal:  Ann Transl Med       Date:  2019-09

Review 3.  Multimodality treatment of brain metastases from renal cell carcinoma in the era of targeted therapy.

Authors:  Bassanelli Maria; Viterbo Antonella; Roberto Michela; Giacinti Silvana; Staddon Anita; Aschelter Anna Maria; D'Antonio Chiara; Marchetti Paolo
Journal:  Ther Adv Med Oncol       Date:  2016-07-25       Impact factor: 8.168

Review 4.  Oral Targeted Therapies and Central Nervous System (CNS) Metastases.

Authors:  Michael P Gabay; Scott M Wirth; Joan M Stachnik; Colleen L Overley; Katie E Long; Linda R Bressler; John L Villano
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

Review 5.  Expert Recommendations for First-Line Management of Metastatic Renal Cell Carcinoma in Special Subpopulations.

Authors:  Javier Puente; Xavier García Del Muro; Álvaro Pinto; Nuria Láinez; Emilio Esteban; José Ángel Arranz; Enrique Gallardo; María José Méndez; Pablo Maroto; Enrique Grande; Cristina Suárez
Journal:  Target Oncol       Date:  2016-04       Impact factor: 4.493

Review 6.  Prognostic Factors and Current Treatment Strategies for Renal Cell Carcinoma Metastatic to the Brain: An Overview.

Authors:  Valeria Internò; Pierluigi De Santis; Luigia Stefania Stucci; Roberta Rudà; Marco Tucci; Riccardo Soffietti; Camillo Porta
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

Review 7.  Targeted therapy of brain metastases: latest evidence and clinical implications.

Authors:  Rodica Di Lorenzo; Manmeet S Ahluwalia
Journal:  Ther Adv Med Oncol       Date:  2017-11-15       Impact factor: 8.168

Review 8.  Multidiscipline Immunotherapy-Based Rational Combinations for Robust and Durable Efficacy in Brain Metastases from Renal Cell Carcinoma.

Authors:  Hye-Won Lee
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

9.  In comparative analysis of multi-kinase inhibitors for targeted medulloblastoma therapy pazopanib exhibits promising in vitro and in vivo efficacy.

Authors:  Rogerio B Craveiro; Michael Ehrhardt; Martin I Holst; Thorsten Pietsch; Dagmar Dilloo
Journal:  Oncotarget       Date:  2014-08-30

10.  Pazopanib-mediated long-term disease stabilization after resection of a uterine leiomyosarcoma metastasis to the brain: A case report.

Authors:  Kayo Inoue; Hiroshi Tsubamoto; Yusuke Tomogane; Mariko Kamihigashi; Hiroaki Shibahara
Journal:  Gynecol Oncol Rep       Date:  2016-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.